This is achieved by suppressing mitochondrial toxicity by reducing the protein levels of cleaved caspase 3 and Htra2 and the protein and mRNA levels of Grp78 and caspase 12 in human neuroblastoma cell lines [139]. The gene discussed is CASP3; the disease is neuroblastoma.